InsiderClue

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 0/25
Result 21,068 decisions over 12 months
Reset filters
Direction ?
Both21,068 Bought5,029 Sold16,039
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Plan: Discretionary Minimum: $100K
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
SON SONOCO PRODUCTS CO
29 Oct 2025
Joachimczyk Paul
CFO
Bought 5×
20,500
$809.75K
opened
IBKR Interactive Brokers
29 Oct 2025
Harris Lawrence E
Director
Sold at will
10,645
$734.51K
5.1%
UVE UNIVERSAL INSURANCE HOLDINGS, INC.
29 Oct 2025
DOWNES SEAN P
Executive Chairman
Sold at will
20,000
$628.07K
1.5%
JBL Jabil
29 Oct 2025
McKay Francis
SVP, Chief Procurement Officer
Sold at will
2,526
$567.00K
5.8%
THC TENET HEALTHCARE CORP
29 Oct 2025
FISHER RICHARD W
Director
Sold at will
2,500
$521.08K
22.1%
UHT UNIVERSAL HEALTH REALTY INCOME TRUST
29 Oct 2025
MILLER ALAN B
President, and CEO
Bought
12,247
$453.40K
7.2%
INV Innventure, Inc.
29 Oct 2025
WE-INN LLC
10% owner
Sold at will
149,708
$437.15K
1.8%
ASA ASA Gold & Precious Metals Ltd
29 Oct 2025
Saba Capital Management, L.P.
10% owner indirect
Bought
9,128
$413.68K
0.2%
WGS GeneDx Holdings Corp.
29 Oct 2025
Stueland Katherine
CHIEF EXECUTIVE OFFICER
Sold at will 2×
2,158
$294.65K
38.6%
HXL HEXCEL CORP /DE/
29 Oct 2025
Winterlich Patrick
EVP, CFO
Sold at will
3,413
$250.31K
7.8%
FIBK FIRST INTERSTATE BANCSYSTEM INC
29 Oct 2025
Scott Jonathan R
10% owner indirect
Sold at will
7,000
$224.63K
0.7%
UHS Universal Health Services
29 Oct 2025
SUSSMAN ELLIOT J MD MBA
Director
Sold at will
965
$217.80K
13.6%
EFSI EAGLE FINANCIAL SERVICES INC
29 Oct 2025
STOKELY JOHN D JR
Director indirect
Sold at will
5,815
$212.83K
100%
BGMS Bio Green Med Solution, Inc.
29 Oct 2025
Yap Kim Choy
10% owner
Sold at will
110,749
$203.11K
44.0%
EBC Eastern Bankshares, Inc.
29 Oct 2025
Rosato R David
Chief Financial Officer indirect
Bought
10,000
$168.80K
33.3%
MEGI NYLI CBRE Global Infrastructure Megatrends Term Fund
29 Oct 2025
Saba Capital Management, L.P.
10% owner indirect
Sold at will
11,621
$168.16K
0.2%
RLAY Relay Therapeutics, Inc.
29 Oct 2025
Rahmer Peter
See remarks
Sold at will
21,394
$160.46K
6.0%
MXL MAXLINEAR, INC
29 Oct 2025
ARTUSI DANIEL A
Director
Sold at will
9,055
$143.70K
21.6%
MERC MERCER INTERNATIONAL INC.
29 Oct 2025
KELLOGG PETER R
10% owner indirect
Bought 4×
58,540
$132.72K
6.4%
GETY Getty Images Holdings, Inc.
29 Oct 2025
Neuberger Berman Group LLC
10% owner indirect
Sold at will
63,000
$130.95K
0.1%
CHMG CHEMUNG FINANCIAL CORP
29 Oct 2025
STREETER JEFFREY B
Director
Bought
2,184
$113.40K
7.2%
CRWV CoreWeave, Inc.
28 Oct 2025
Magnetar Financial LLC
10% owner indirect
Sold at will 79×
1,453,605
$201.49M
82.6%
MPLT MapLight Therapeutics, Inc.
28 Oct 2025
Catalyst4, Inc.
10% owner indirect
Bought
5,441,176
$92.50M
38.2%
MTSI MACOM Technology Solutions Holdings, Inc.
28 Oct 2025
OCAMPO SUSAN
10% owner indirect
Sold at will
124,515
$18.43M
4.6%
MPLT MapLight Therapeutics, Inc.
28 Oct 2025
Novo Holdings A/S
10% owner
Bought
952,941
$16.20M
34.9%
ORCL Oracle Corporation
28 Oct 2025
BERG JEFFREY
Director indirect
Sold at will 4×
49,365
$13.97M
24.5%
SCHW Charles Schwab Corporation
28 Oct 2025
Schwab Charles R.
Co-Chairman indirect
Sold at will
64,400
$6.05M
0.1%
VOR Vor Biopharma Inc.
28 Oct 2025
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Sold at will 2×
124,311
$3.41M
10.5%
SION Sionna Therapeutics, Inc.
28 Oct 2025
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Sold at will 4×
62,610
$2.48M
23.0%
TRV Travelers Companies (The)
28 Oct 2025
Klein Michael Frederick
EVP & President, Personal Ins.
Sold at will 2×
8,572
$2.32M
20.3%
ANVS Annovis Bio, Inc.
28 Oct 2025
Hoffman Michael B
Director
Bought
975,610
$2.00M
65.9%
AYI ACUITY INC. (DE)
28 Oct 2025
GOLDMAN BARRY R
SVP & General Counsel
Sold at will 7×
4,489
$1.64M
42.6%
WCN Waste Connections, Inc.
28 Oct 2025
GUILLET EDWARD E
Director
Sold at will
9,000
$1.57M
37.7%
CGEM Cullinan Therapeutics, Inc.
28 Oct 2025
Lynx1 Capital Management LP
10% owner indirect
Bought
165,667
$1.39M
1.9%
APLD Applied Digital Corp.
28 Oct 2025
Mohmand Mohammad Saidal LaVanway
Chief Financial Officer
Sold at will
37,503
$1.37M
23.6%
VKTX Viking Therapeutics, Inc.
28 Oct 2025
Lian Brian
President & CEO
Sold at will
38,989
$1.36M
1.6%
EBC Eastern Bankshares, Inc.
28 Oct 2025
Rivers Robert Francis
Executive Chair
Bought
50,000
$860.50K
14.2%
BY BYLINE BANCORP, INC.
28 Oct 2025
ABRAHAM THOMAS
PRESIDENT, SBC
Sold at will 2×
23,400
$629.15K
37.6%
ASA ASA Gold & Precious Metals Ltd
28 Oct 2025
Saba Capital Management, L.P.
10% owner indirect
Bought
12,847
$582.23K
0.3%
IRDM Iridium Communications Inc.
28 Oct 2025
NIEHAUS ROBERT H
Director
Bought
30,000
$524.70K
11.2%
IBKR Interactive Brokers
28 Oct 2025
Harris Lawrence E
Director
Sold at will
6,855
$474.02K
3.2%
WAB Wabtec
28 Oct 2025
DeNinno David L
Exec VP, General Counsel, Sec.
Sold at will
2,100
$419.73K
3.4%
VICR VICOR CORP
28 Oct 2025
Gusinov Alex
Corp. Vice President Eng.
Sold at will
4,019
$360.71K
24.1%
VICR VICOR CORP
28 Oct 2025
Lavie Zmira
Director
Sold at will 3×
3,720
$333.24K
100%
MEGI NYLI CBRE Global Infrastructure Megatrends Term Fund
28 Oct 2025
Saba Capital Management, L.P.
10% owner indirect
Sold at will
21,797
$317.58K
0.3%
RNTX Rein Therapeutics, Inc.
28 Oct 2025
Voss Capital, LP
10% owner indirect
Bought
178,392
$247.96K
55.5%
MRP Millrose Properties, Inc.
28 Oct 2025
BARTELS PATRICK J JR
Director
Bought
7,500
$243.86K
32.4%
RLAY Relay Therapeutics, Inc.
28 Oct 2025
Bergstrom Donald A
President, R&D
Sold at will
30,897
$225.24K
5.6%
VKTX Viking Therapeutics, Inc.
28 Oct 2025
Mancini Marianna
Chief Operating Officer
Sold at will
6,185
$216.49K
1.6%
VKTX Viking Therapeutics, Inc.
28 Oct 2025
ZANTE GREG
Chief Financial Officer
Sold at will
6,185
$216.48K
3.4%
Showing 20,401–20,450 of 21,068. ← Newer Page 409 of 422 Older →